Joseph is a clinical and translational postdoctoral fellow, Abey is a nurse specialist, and Henderson is investigator and chief of the Digestive Disorder Unit, all in the Biobehavioral Branch of the Division of Intramural Research in the National Institute of Nursing Research at the National Institutes of Health (NIH) Nutrition is a factor involved in inflammation and a modulator of risk toward some cancers, and the complexity of linkages between dietary components and epigenetics mechanisms (e.g., DNA methylation, histone modification, chromatin remodeling) may affect the inflammation phenotype and the development of cancer. An increasing number of studies support the role of diet in cancer development, prevention, and treatment. Although current knowledge regarding nutriepigenetics is expanding, more work is needed, and nurse scientists have the potential to significantly contribute to the expansion of this knowledge. D isease risk and development are influenced by many factors (e.g., lifestyle, environment, nutrition) and genetics. Evidence shows that these factors interact with one another in ways that are unique to each person, making quantification of the risks of developing diseases such as cancer challenging. Cancer is a metabolically driven process with dynamic nutrient-responsive alterations within the human genome (Vander Heiden, Cantley, & Thompson, 2009 ). The epigenetic machinery acting on the human genome is heavily susceptible to alterations in metabolism and nutrition, particularly during periods of inflammation (Keating & El-Osta, 2015) . This emerging knowledge leads to current interest in nutriepigenetics or nutri-epigenomics. Epigenetics focuses on processes that regulate how and when certain genes are turned on and off, whereas epigenomics refers to analysis of global epigenetic changes across many genes, made possible by highthroughput methods. Therefore, nutri-epigenetics focuses on the process by which nutrition regulates how one specific gene is turned on or off, whereas nutri-epigenomics refers to the analysis of the interaction among multitudes of genes and nutrition, as well as the effects on global gene expression, which may vary among different tissues. This article aims to provide a brief overview of epigenetics and how it can be affected by metabolism and nutrition, discuss nutri-epigenetics and cancer, and consider the implications of nutri-epigenetics knowledge and evidence for nursing practice.
Background
The fields of both epigenetics and epigenomics have been empowered by publicly available databases (e.g., Human Epigenome Browser from Washington University School of Medicine in St. Louis; epigenome gateway.wustl.edu/info) that have focused on gathering epigenetics sequences for epigenome-wide association studies. These studies have demonstrated that epigenetic alterations related to food components and environmental (nutrition) factors, along with other genetic mutations, play a role in the development of inflammatory diseases, such as cancer (van Veldhoven et al., 2015) . The field of nutriepigenomics provides new insights into diet-genome interactions, and these insights have permitted explorations of the use of metabolically based drugs, such as metformin (Glucophage ® ), as part of cancer therapy (Kasznicki, Sliwinska, & Drzewoski, 2014) and the design of nutrition-and lifestyle-based cancer management strategies (Richman et al., 2013) .
The term epigenetics was introduced to describe the interactions between genes and the environment that gave rise to phenotypes during development; it has been expanded to include environmentally responsive cellular processes that can be heritable and have long-term
